https://insights.citeline.comTue, 12 Nov 2024 09:39:56 +0000en1hourly1https://insights.citeline.com/generics-bulletin/business/earnings/hikma-stays-on-track-by-bolstering-injectables-and-generics-YJ4TXEAWQVH7ZIDPKPYNPHWARA/https://insights.citeline.com/generics-bulletin/business/earnings/hikma-stays-on-track-by-bolstering-injectables-and-generics-YJ4TXEAWQVH7ZIDPKPYNPHWARA/Mon, 11 Nov 2024 12:23:22 +0000https://insights.citeline.com/generics-bulletin/products/value-added-medicines/teva-welcomes-potential-for-olanzapine-running-start-amid-positive-clinical-data-SG5B2Z5YRRBWPD4ENUJVWPK6G4/https://insights.citeline.com/generics-bulletin/products/value-added-medicines/teva-welcomes-potential-for-olanzapine-running-start-amid-positive-clinical-data-SG5B2Z5YRRBWPD4ENUJVWPK6G4/Mon, 11 Nov 2024 12:08:21 +0000https://insights.citeline.com/generics-bulletin/products/biosimilars/igba-kicks-off-global-biosimilars-week-2024-A4NJ4ZSDTBBJNE6Y4MCRVML6DI/https://insights.citeline.com/generics-bulletin/products/biosimilars/igba-kicks-off-global-biosimilars-week-2024-A4NJ4ZSDTBBJNE6Y4MCRVML6DI/Mon, 11 Nov 2024 11:59:01 +0000